CoChat

Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist

Komesli, Sylviane, Vivien, Denis, Dutartre, Patrick · 1998 · European Journal of Biochemistry
Cited by 63

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Transforming growth factor‐β (TGF‐β) type‐I and type‐II receptors form a ligand‐dependent heteromeric signalling complexes, in which transforming growth factor‐β receptor type II (TβRII) trends to act as the primary receptor. In the present study, we used a chimeric soluble type‐II receptor fused with the Fc regions of human immunoglobulin (TβRIIs‐Fc) in order to obtain a putative TGF‐β antagonist. Biochemical studies revealed that TβRIIs‐Fc shared the same properties as the wild‐type receptor. The TβRIIs‐Fc receptor displayed an affinity of 1370 ± 363 pM which was similar to those of the wild‐type TβRII when expressed alone in Cos‐1 cells (1122 ± 413 pM). Furthermore, the chimeric receptor showed the same selectivity for TGF‐β isoforms as the native receptor. Although both TGF‐β1 and TGF‐β3 were able to bind TβRIIs‐Fc, TGF‐β2 could not compete with the binding of TGF‐β1 to TβRIIs‐Fc. It was noted that this type of fused Fc receptor could be used in FlashPlate screening for potent agonism and antagonism of TGFβ. Moreover, biological activities of the chimeric receptor showed it to be a potent TGF‐β1‐antiproliferative and TGF‐β1‐extracellular matrix transcriptional inhibitor on responses in Mv1Lu cells. To conclude, our results clearly show that the TβRIIs‐Fc chimeric receptor could be used as a potent TGF‐β antagonist. These data raised the possibility that this TβRIIs‐Fc construct might act successfully as an antagonist of both TGF‐β1 and TGF‐β3 in vivo.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1432-1327.1998.2540505.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 63

Metadata

Authors
Komesli, S., Vivien, D., & Dutartre, P.
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1998-06-15
Volume
254
Issue
3
Pages
505-513
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
OpenAlex
W2018075165
Cited by
63
References
1
FWCI
1.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist. https://app.cochat.ai/papers/10.1046/j.1432-1327.1998.2540505.x
The paper
Komesli, S., Vivien, D., & Dutartre, P. (1998). Chimeric extracellular domain of type II transforming growth factor (TGF)‐β receptor fused to the Fc region of human immunoglobulin as a TGF‐β antagonist. European Journal of Biochemistry. https://doi.org/10.1046/j.1432-1327.1998.2540505.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.